According to statistics, nearly 40% of adults in China suffer from blood lipid abnormalities, with only about 30% of patients aware of their condition. The control rate of blood lipid levels is less than 10%. Although blood lipid abnormalities are common, many people do not know when to check their blood lipid levels or what the control targets are for blood lipid levels.
Experts point out that regular health check-ups are an important way to detect blood lipid abnormalities. It is recommended that adults between the ages of 20 and 40 have their blood lipid levels checked at least once every 5 years, while adults over 40 should have their blood lipid levels checked every year. For patients with atherosclerotic cardiovascular disease and those at high risk, blood lipid levels should be checked every 3-6 months.
The risk of atherosclerotic cardiovascular disease can be assessed by evaluating the patient's overall risk factors, including high blood pressure, high blood sugar, high cholesterol, and smoking. The patient's risk factors can be classified into four categories: extremely high risk, high risk, medium risk, and low risk.
The treatment target for low-density lipoprotein cholesterol (LDL-C) is less than 1.8 mmol/L for patients with extremely high risk, and less than 2.6 mmol/L for patients with high risk. For patients with medium risk, the treatment target for LDL-C is less than 3.4 mmol/L.
Experts remind us that it is essential to undergo regular blood lipid checks and to control blood lipid levels according to individual risk factors. This can help prevent the onset of atherosclerotic cardiovascular disease and reduce the risk of heart attacks and strokes.
In conclusion, blood lipid abnormalities are a significant risk factor for cardiovascular disease, and regular check-ups and control of blood lipid levels are crucial for preventing and managing the condition. By understanding the risks and taking preventive measures, we can reduce the burden of cardiovascular disease and promote overall health and well-being.